Should I buy Allstate (ALL) stock or is it too late?

Allstate · Financials · price $236

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: Roth MKM — 84% of its targets hit on this sector (25 calls tested). It aims for $300 (+27 %), call made on August 7, 2026, maturing on August 7, 2027 (68 d ago).

The 12 reliable analysts $256+8.3 %

The 5 other firms $295+25 %

How to read it: the 12 reliable firms are not filtered by optimism — 8 aim above the price, 4 below, hence their $256 median. “The 5 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Allstate

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
Piper Sandler	89 %	+23.1 %	19	$300 +27%
UBS	91 %	+18.6 %	11	$275 +16%
Keefe, Bruyette & Woods	96 %	+17.4 %	23	$232 -2%
Morgan Stanley	100 %	+15.0 %	8	$240 +2%
Raymond James	72 %	+14.3 %	25	$300 +27%
Goldman Sachs	85 %	+13.4 %	13	$250 +6%
BMO Capital	100 %	+11.4 %	5	$284 +20%
Citigroup	67 %	+10.1 %	27	$215 -9%

In short — Should you invest in Allstate? Is it too late, still worth it? Analysts are split (39% buy, median target $264, i.e. +12%), and the most reliable on ALL targets even higher. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

Median price target $264, i.e. +12% from the current price ($236).
The most reliable firm on ALL, Roth MKM (100% hit rate, 3 scored calls), targets $300 (call made on August 6, 2026, maturing on August 6, 2027) (+27%) in its most recent call.
Pays a dividend (1.7% yield), raised for 15 years — regular income on top of potential upside.
Reasonable valuation (P/E ~5) relative to its sector.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 18 ratings, 8 are neutral and 3 are sells.
A 12-month target is not a guaranteed path: the price can fall in the meantime.

The analyst consensus on ALL

Median target $264 (+12%) · 18 ratings · Hold consensus

Strong Buy16%

Buy633%

Hold844%

Sell317%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Allstate now?

We won't decide for you. The facts: 39% of analysts rate it a buy, median target $264 (+12%), and Roth MKM (most reliable on ALL, 100%) targets $300. Weigh that against valuation (P/E ~5). This is not personalized advice.

Is it too late to invest in Allstate?

Not according to analysts: the median target ($264) is still +12% above the current price ($236) (most reliable on ALL: Roth MKM, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Allstate still worth investing in?

It depends on the gap between the price ($236) and its estimated value: analysts target $264 on median (+12%), with 39% buys (most reliable on ALL: Roth MKM, 100%). Cross-check with their real reliability on ALL and the cautions above. Information, not advice.

What's the main risk in buying ALL?

The consensus is not unanimous: of 18 ratings, 8 are neutral and 3 are sells.

→ Go deeper: the full Allstate profile (consensus, analyst reliability, price target, performance).